Products Categories
CAS No.: | 30045-16-0 |
---|---|
Name: | Dehydrocorydaline |
Article Data: | 8 |
Molecular Structure: | |
Formula: | C22H24 N O4 |
Molecular Weight: | 366.437 |
Synonyms: | Berbinium,7,8,13,13a-tetradehydro-2,3,9,10-tetramethoxy-13-methyl- (8CI);Corydaline, dehydro-(7CI);13-Methylpalmatine;Dehydrocorydaline;2,3,9,10-tetramethoxy-13-methyl-5,6-dihydro-isoquino[3,2-a]isoquinolinylium;13-Methyl-2,3,9,10-tetramethoxy-5,6-dihydrodibenzo[a,g]quinolizinium;5,6-Dihydro-2,3,9,10-tetramethoxy-13-methyldibenzo[a,g]quinolizinium; |
Density: | g/cm3 |
Melting Point: | 170-173 oC |
Boiling Point: | °Cat760mmHg |
Flash Point: | °C |
Appearance: | Orange Powder |
PSA: | 40.80000 |
LogP: | 3.69320 |
Dehydrocorydaline inhibits breast cancer cells proliferation, through induction of apoptosis.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 78mg/kg (78mg/kg) | Yakugaku Zasshi. Journal of Pharmacy. Vol. 84, Pg. 73, 1964. |
Safety Info | |
HS Code: | 2933990090 |
---|
Dehydrocorydaline inhibits breast cancer cells proliferation, through induction of apoptosis.